Pay in 4 interest-free payments of $5.07 Learn more
Ships within 48 hours · Estimated delivery Aug 8 - Aug 13
Outcomes vary by individual, and no specific results are guaranteed
It is important to note that semaglutide is not approved for use with type 1 diabetes or diabetic ketoacidosis
Semaglutide 7.2 mg received FDA approval to reduce excess body weight and maintain long-term weight reduction in adults with obesity or overweight with at least 1 weight-related condition
In general, and similar to FDA-approved labeling for GLP-1 weight-management medications, you may be considered for a GLP-1 prescription if you: Have a BMI of 30 or higher (obesity), or Have a BMI between 2729.9 (overweight) plus a weight-related health condition Weight-related conditions can include high blood pressure, type 2 diabetes, sleep apnea, high cholesterol, or PCOS (Polycystic Ovary Syndrome), for example
The page also repeats the lab-only restriction
Indice Farmaci GLP-1: come reagiscono i pazienti
US$ 28.39
US$ 26.78
US$ 21.47
US$ 25.78
US$ 27.46
:max_bytes(150000):strip_icc()/GettyImages-1299286851-18ab6e02931940ad963dda93851b6dc7.jpg)
US$ 21.47
